← Leaderboards
Weiqing Li
Massachusetts General Hospital
$754,322
Attributed
$754,322
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $319.8K · FY2010–11$500K$375K$250K$125K$0
'10
'11
Funding mix
By agency
NIH$754,322 · 2
By mechanism
R01$627,192 · 1
F32$127,130 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Gary B. Ruvkun$40,968,557
- Richard W Olsen$8,370,197
- William F Crowley$27,565,527
- Stuart A Forman$18,759,710
- Michael Leo Fitzgerald$6,905,590
Others in their field
Top investigators on “Longevity”
- Chanza Baytop · Westat, Inc.$146,068,012
- Lee Marshall Nadler · Dana-Farber Cancer Inst$90,363,087
- Michael A Province · Washington University$72,611,872
- Judith Kasper · Johns Hopkins University$69,575,962
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$64,213,010
- Thomas T Perls · Beth Israel Deaconess Medical Center$61,138,423
Research focus
LongevityInsulin ReceptorCaenorhabditis ElegansDiapauseTranscription FactorInsulinlike FactorTransforming Growth FactorsBiological Signal TransductionDown-RegulationGenesDiabetes MellitusAnimalsDegradation PathwayEndocrineCuesBiological Adaptation To StressFamilyEventFeedingFunctional GenomicsGene FunctionGenerationsCholesterol TransportersEtiology
Grant awards (5)
Endocrine Regulation of Survival Responses in C. elegans$307,392
R01 · FY2011 · AG · contact PI
Endocrine Regulation of Survival Responses in C. elegans$319,800
R01 · FY2010 · AG · contact PI
LONGEVITY AND DIAPAUSE IN C ELEGANS$47,648
F32 · FY2002 · AG
LONGEVITY AND DIAPAUSE IN C ELEGANS$41,966
F32 · FY2001 · AG
LONGEVITY AND DIAPAUSE IN C ELEGANS$37,516
F32 · FY2000 · AG